Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer

RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer

(2014) Õsa Ehlén et al.   Translational Oncology

A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

(2012) Joshua J. Meeks et al.   EUROPEAN UROLOGY

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

(2012) Cora N. Sternberg et al.   EUROPEAN UROLOGY

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

(2011) Liv Jonsson et al.   Diagnostic Pathology

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study

(2011) Liv Jonsson et al.   Journal of Translational Medicine

High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

(2011) Barbara Hjelm et al.   Proteomics Clinical Applications

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

(2010) Åsa Ehlén et al.   Journal of Translational Medicine

Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

(2009) Annika Jögi et al.   MODERN PATHOLOGY

The RNA-Binding Protein RBM3 Is Required for Cell Proliferation and Protects Against Serum Deprivation-Induced Cell Death

(2009) Sven Wellmann et al.   PEDIATRIC RESEARCH

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe

(2008) S M Sureban et al.   ONCOGENE